Cargando…

Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them

BACKGROUND: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Yundi, Sun, Zhaoqing, Xie, Yanxia, Zheng, Jia, Li, Zhao, Guo, Xiaofan, Dai, Yue, Zheng, Liqiang, Sun, Yingxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236183/
https://www.ncbi.nlm.nih.gov/pubmed/32429909
http://dx.doi.org/10.1186/s12872-020-01523-z
_version_ 1783536111068381184
author Jiao, Yundi
Sun, Zhaoqing
Xie, Yanxia
Zheng, Jia
Li, Zhao
Guo, Xiaofan
Dai, Yue
Zheng, Liqiang
Sun, Yingxian
author_facet Jiao, Yundi
Sun, Zhaoqing
Xie, Yanxia
Zheng, Jia
Li, Zhao
Guo, Xiaofan
Dai, Yue
Zheng, Liqiang
Sun, Yingxian
author_sort Jiao, Yundi
collection PubMed
description BACKGROUND: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline compared with the same parameters according to the 2010 Chinese guideline. METHODS: We used 2011 data from the China Health and Nutrition Survey (CHNS). A total of 12,499 Chinese adults aged ≥18 years with complete blood pressure (BP) values were selected for the present analysis. RESULTS: The crude prevalence rates (95% CI) of hypertension according to the definitions from the 2017 ACC/AHA guideline and the 2010 Chinese guideline were 58.0% (57.2 to 58.9%) and 25.4% (24.7 to 26.2%), respectively. Moreover, the percentage of the participants recommended to take antihypertensive medications were 31.5 and 28.8%, respectively. Among adults who took antihypertensive medications, 88.8% had above-goal BP levels compared to 53.3%. Overall, 613.3 million Chinese adults (aged ≥18 years) met the criteria for hypertension according to the 2017 ACC/AHA guideline, and 267.7 million met the criteria according to 2010 Chinese guideline. An additional 28.4 million (2.7%) Chinese adults were recommended to take antihypertensive medication. CONCLUSIONS: The present analysis revealed that the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage and number of Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended to take antihypertensive medications compared to the same parameters based on the 2010 Chinese guideline. More intensive management and antihypertensive medications use are suggested to improve the control rate of hypertension among Chinese adults.
format Online
Article
Text
id pubmed-7236183
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72361832020-05-27 Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them Jiao, Yundi Sun, Zhaoqing Xie, Yanxia Zheng, Jia Li, Zhao Guo, Xiaofan Dai, Yue Zheng, Liqiang Sun, Yingxian BMC Cardiovasc Disord Research Article BACKGROUND: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline compared with the same parameters according to the 2010 Chinese guideline. METHODS: We used 2011 data from the China Health and Nutrition Survey (CHNS). A total of 12,499 Chinese adults aged ≥18 years with complete blood pressure (BP) values were selected for the present analysis. RESULTS: The crude prevalence rates (95% CI) of hypertension according to the definitions from the 2017 ACC/AHA guideline and the 2010 Chinese guideline were 58.0% (57.2 to 58.9%) and 25.4% (24.7 to 26.2%), respectively. Moreover, the percentage of the participants recommended to take antihypertensive medications were 31.5 and 28.8%, respectively. Among adults who took antihypertensive medications, 88.8% had above-goal BP levels compared to 53.3%. Overall, 613.3 million Chinese adults (aged ≥18 years) met the criteria for hypertension according to the 2017 ACC/AHA guideline, and 267.7 million met the criteria according to 2010 Chinese guideline. An additional 28.4 million (2.7%) Chinese adults were recommended to take antihypertensive medication. CONCLUSIONS: The present analysis revealed that the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage and number of Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended to take antihypertensive medications compared to the same parameters based on the 2010 Chinese guideline. More intensive management and antihypertensive medications use are suggested to improve the control rate of hypertension among Chinese adults. BioMed Central 2020-05-19 /pmc/articles/PMC7236183/ /pubmed/32429909 http://dx.doi.org/10.1186/s12872-020-01523-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Jiao, Yundi
Sun, Zhaoqing
Xie, Yanxia
Zheng, Jia
Li, Zhao
Guo, Xiaofan
Dai, Yue
Zheng, Liqiang
Sun, Yingxian
Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them
title Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them
title_full Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them
title_fullStr Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them
title_full_unstemmed Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them
title_short Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them
title_sort potential impacts of the 2017 american college of cardiology/american heart association high blood pressure guideline on chinese adults and how to address them
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236183/
https://www.ncbi.nlm.nih.gov/pubmed/32429909
http://dx.doi.org/10.1186/s12872-020-01523-z
work_keys_str_mv AT jiaoyundi potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT sunzhaoqing potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT xieyanxia potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT zhengjia potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT lizhao potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT guoxiaofan potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT daiyue potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT zhengliqiang potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem
AT sunyingxian potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem